Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2
3(100.0%)
3Total
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05542615Phase 2Unknown

Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).

Role: collaborator

NCT02805257Phase 2Completed

Ahmed Glaucoma Valve Surgery With Mitomycin-C

Role: collaborator

NCT05315596Enrolling By Invitation

Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery

Role: collaborator

NCT04542967Phase 2Completed

Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease

Role: lead

All 4 trials loaded